In-silico binding affinity of a phage display library screened novel peptide against various FABPs

Harshita Shand1, Soumendu Patra1, Bavya Chandrasekhar2

  • 1Department of Microbiology, Raiganj University, Uttar Dinajpur, Raiganj, West Bengal India.

In Silico Pharmacology
|August 26, 2024
PubMed

Insights

A novel peptide shows promise for detecting heart damage by binding to Heart-type fatty acid binding protein (H-FABP). This discovery could lead to faster point-of-care diagnostics for acute myocardial infarction (AMI), improving patient outcomes.

Area of Science:

  • Biochemistry
  • Cardiovascular Research
  • Biomarker Discovery

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of death.
  • Heart-type fatty acid binding protein (H-FABP) is a key biomarker for myocardial damage and ischemia.
  • Early detection of acute myocardial infarction (AMI) is crucial for reducing mortality and healthcare burden.

Purpose of the Study:

  • To discover and characterize a peptide-based detection system for H-FABP.
  • To evaluate the potential of a novel peptide for point-of-care diagnostics of cardiac conditions.
  • To assess the binding affinity and suitability of the peptide for H-FABP detection.

Main Methods:

  • Phage Display Library Screening was used to identify a 12-amino acid peptide.
  • Molecular docking studies (HDOCK server) were performed to analyze peptide-protein interactions.
  • Molecular simulations (RMSD, RMSF, radius of gyration) were conducted to validate binding affinity.
  • ADMET profiling was performed to assess pharmacokinetic properties.

Main Results:

  • A 12-amino acid peptide was identified with significant binding affinity for H-FABP.
  • Molecular docking revealed specific binding sites and poses between the peptide and H-FABP.
  • Molecular simulations confirmed the binding affinity, with bond lengths ranging from 2.3 to 3.4 Å.
  • The peptide demonstrated suitability for binding with H-FABP.

Conclusions:

  • The screened peptide is a promising candidate for H-FABP detection.
  • This peptide-based approach holds potential for developing point-of-care diagnostics for cardiac ischemia.
  • The findings support the use of this peptide for prognostic purposes in heart ischemic conditions.